material misstatement

Class action lawsuit filed against $QURE over alleged misstatements about AMT-130 gene therapy FDA approval status. Stock plunged 49% after FDA reversed position on Phase I/II data adequacy.

Vistagen faces securities fraud lawsuit over fasedienol trial misstatements. Affected investors have until March 16, 2026 deadline to seek lead plaintiff status or secure counsel.

Kahn Swick & Foti, LLC filed class action lawsuits against Navan, Kyndryl, and Ultragenyx for alleged securities disclosure violations. Lead plaintiff applications due April 24, 2026.

CoreWeave faces class action securities fraud lawsuit alleging overstatement of capacity and understatement of supplier risks between March-December 2025. Lead plaintiff applications due March 13, 2026.

Class action lawsuit filed against $FBRT for allegedly misleading investors about dividend sustainability. Stock plunged 14.2% after February disclosure of capital over-distribution.

Beyond Meat faces securities class action over asset valuation disclosures spanning Feb-Nov 2025. Lead plaintiff deadline March 24, 2026.

Franklin BSP Realty Trust faces class action lawsuit over allegedly false dividend sustainability claims, affecting investors from November 2024 through February 2026.

Rosen Law Firm files class action against PayPal for allegedly misleading investors about 2027 financial targets and Branded Checkout growth potential.

Class action filed against Varonis Systems for allegedly concealing inability to maintain ARR growth. Stock plunged 48.7% after October earnings revealed 63.9% revenue decline.

NuScale Power faces securities fraud lawsuit over failing to disclose risks associated with a $495 million ENTRA1 deal. Stock fell 12.4% after November disclosure.

CoreWeave faces securities class action for allegedly omitting material disclosures about operational risks and supply chain vulnerabilities. Investors with losses over $100K must apply by March 13, 2026.

Class action investigations launched against Ramaco Resources and Beyond Meat for alleged securities violations. Investors face deadlines of March 31 and March 24, 2026, respectively, to petition as lead plaintiffs.

REGENXBIO faces class action lawsuit alleging false statements about gene therapy RGX-111's safety and efficacy. Investors must act by April 14, 2026 deadline.

PomDoctor faces class action lawsuit alleging fraudulent stock promotion scheme involving false statements, insider sales, and market manipulation between October-December 2025.

Beyond Meat faces class action lawsuit alleging false asset valuations. Investors have until March 24, 2026 to join litigation over securities purchased February 2025-November 2025.

Ramaco Resources faces class action lawsuit for allegedly misleading investors about Brook Mine operations. Executives reportedly made false statements about the facility's status despite holding a public groundbreaking ceremony.

Beyond Meat faces class action lawsuit alleging leadership concealed material asset impairment charges, misleading investors during nine-month period ending November 2025.

CoreWeave faces securities class action alleging material misrepresentations about capacity and concealed data center supplier risks. Lead plaintiff applications due March 13, 2026.

Rosen Law Firm sues Picard Medical for alleged fraudulent stock promotion and concealment of adverse information. Investors must act before April 13, 2026 deadline to become lead plaintiff.

Rosen Law Firm sues BlackRock TCP Capital Corp. for alleged financial misstatements and improper valuations. Investors must act by April 6, 2026 deadline.